Czech National Bank Grows Stock Holdings in Axon Enterprise, Inc $AXON

Key Points

• The Czech National Bank increased its holdings in Axon Enterprise, Inc by 8.7%, owning 18,078 shares valued at approximately $14.97 million after acquiring an additional 1,440 shares in the second quarter.
• Several analysts set optimistic price targets for Axon Enterprise, with estimates ranging from $800 to $870, contributing to a consensus "Moderate Buy" rating for the stock.
• In recent insider trading, President Joshua Isner sold 15,919 shares for about $11.88 million, reducing his ownership position by 6.26%.

Czech National Bank raised its position in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 8.7% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,078 shares of the biotechnology company's stock after purchasing an additional 1,440 shares during the period. Czech National Bank's holdings in Axon Enterprise were worth $14,967,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Fourth Dimension Wealth LLC purchased a new stake in Axon Enterprise during the fourth quarter valued at about $30,000. TCTC Holdings LLC grew its stake in shares of Axon Enterprise by 75.0% in the first quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company's stock worth $29,000 after purchasing an additional 24 shares during the last quarter. Bartlett & CO. Wealth Management LLC grew its stake in shares of Axon Enterprise by 132.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock worth $31,000 after purchasing an additional 33 shares during the last quarter. Catalyst Capital Advisors LLC bought a new stake in Axon Enterprise during the 1st quarter valued at approximately $32,000. Finally, Banque Transatlantique SA bought a new stake in Axon Enterprise during the 1st quarter valued at approximately $31,000. Hedge funds and other institutional investors own 79.08% of the company's stock.

Analysts Set New Price Targets

Several analysts have weighed in on AXON shares. Northland Securities set a $800.00 price objective on Axon Enterprise in a research report on Tuesday, August 5th. JMP Securities lifted their price objective on Axon Enterprise from $725.00 to $825.00 and gave the company a "market outperform" rating in a research report on Tuesday, July 22nd. JPMorgan Chase & Co. lifted their target price on shares of Axon Enterprise from $730.00 to $850.00 and gave the company an "overweight" rating in a report on Thursday, July 17th. Zacks Research lowered shares of Axon Enterprise from a "strong-buy" rating to a "hold" rating in a report on Tuesday, September 2nd. Finally, Needham & Company LLC set a $870.00 target price on shares of Axon Enterprise and gave the company a "buy" rating in a report on Tuesday, August 5th. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $837.69.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $750.67 on Wednesday. Axon Enterprise, Inc has a twelve month low of $376.53 and a twelve month high of $885.91. The firm has a market cap of $58.93 billion, a P/E ratio of 185.35, a PEG ratio of 27.92 and a beta of 1.40. The company has a 50 day moving average of $759.48 and a 200 day moving average of $690.43. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, topping analysts' consensus estimates of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The company had revenue of $668.54 million during the quarter, compared to analyst estimates of $641.77 million. During the same period in the previous year, the business earned $1.20 EPS. The firm's revenue for the quarter was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, research analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, President Joshua Isner sold 15,919 shares of the business's stock in a transaction on Friday, August 15th. The shares were sold at an average price of $746.26, for a total transaction of $11,879,712.94. Following the completion of the sale, the president directly owned 238,379 shares in the company, valued at approximately $177,892,712.54. The trade was a 6.26% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Jennifer H. Mak sold 77 shares of the business's stock in a transaction on Monday, September 15th. The shares were sold at an average price of $760.00, for a total transaction of $58,520.00. Following the sale, the chief accounting officer owned 15,003 shares of the company's stock, valued at approximately $11,402,280. This represents a 0.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 44,932 shares of company stock worth $34,408,816. 5.70% of the stock is owned by corporate insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.